Axsome succeeds in late-stage trial for ADHD therapy
Axsome Therapeutics (AXSM) stock gains as solriamfetol, its experimental drug for ADHD succeeds in a Phase 3 trial. Read more ...
Today2d
One dose of experimental drug nearly wipes out stealthy cholesterol in ‘remarkable’ trial
A single dose of an experimental drug dramatically reduced ... showed the drug was safe. The latest study, a Phase 2 clinical trial funded by Lilly, included 320 people. One injection, researchers ...
Hosted on MSN6mon
How do we really think about infinity? New research offers insights
A recent study published in the Journal of Experimental Psychology: Learning, Memory, and Cognition suggests that people do not perceive the infinity symbol (∞) as representing an endless and ...
Leap Therapeutics, Inc.: Leap Therapeutics Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study
Updated data confirms statistically significant 32% higher ORR and 3.5 month longer PFS in second-line CRC patients with high DKK1 levels treated with sirexatamab plus ...